
P547: CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH ACUTE MYELOID LEUKAEMIA TREATED WITH VENETOCLAX COMBINATION THERAPY: REAL‐WORLD EXPERIENCE IN BOTH FRONTLINE AND RELAPSED/REFRACTORY SETTINGS
Author(s) -
Lam H. P. J.,
Leong S.,
Kirkham Z.,
Wilson A.,
Burt R.,
Sellar R.,
Fielding A.,
Gupta R.,
Payne E.,
Mansour M.,
Kottaridis P.,
Khwaja A.,
O'Nions J.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000845076.68865.45
Subject(s) - medicine , venetoclax , cytarabine , azacitidine , ven , oncology , pediatrics , chemotherapy , leukemia , biochemistry , gene expression , chemistry , computer security , chronic lymphocytic leukemia , computer science , dna methylation , gene